Filing Details
- Accession Number:
- 0001225208-13-024294
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-11-26 16:04:03
- Reporting Period:
- 2013-11-22
- Filing Date:
- 2013-11-26
- Accepted Time:
- 2013-11-26 16:04:03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 885725 | Boston Scientific Corp | BSX | Surgical & Medical Instruments & Apparatus (3841) | 042695240 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1224108 | D Jeffrey Capello | One Boston Scientific Place Natick MA 01760-1537 | Evp & Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-11-22 | 100,536 | $8.30 | 247,983 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2013-11-22 | 48,503 | $7.75 | 296,486 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2013-11-22 | 961 | $7.41 | 297,447 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-11-22 | 150,000 | $12.02 | 147,447 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2013-11-25 | 116,459 | $7.16 | 263,906 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2013-11-25 | 87,366 | $7.75 | 351,272 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2013-11-25 | 35,418 | $6.91 | 386,690 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2013-11-25 | 3,261 | $7.74 | 389,951 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-11-25 | 242,504 | $12.02 | 147,447 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2013-11-22 | 961 | $0.00 | 961 | $7.41 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2013-11-22 | 48,503 | $0.00 | 48,503 | $7.75 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2013-11-22 | 100,536 | $0.00 | 100,536 | $8.30 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2013-11-25 | 87,366 | $0.00 | 87,366 | $7.75 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2013-11-25 | 3,261 | $0.00 | 3,261 | $7.74 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2013-11-25 | 116,459 | $0.00 | 116,459 | $7.16 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2013-11-25 | 35,418 | $0.00 | 35,418 | $6.91 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 158,655 | 2020-02-16 | No | 4 | M | Direct | |
| 132,656 | 2020-02-23 | No | 4 | M | Direct | |
| 0 | 2019-02-24 | No | 4 | M | Direct | |
| 45,290 | 2020-02-23 | No | 4 | M | Direct | |
| 1,087 | 2020-02-26 | No | 4 | M | Direct | |
| 116,460 | 2021-02-28 | No | 4 | M | Direct | |
| 44,454 | 2021-05-12 | No | 4 | M | Direct |
Footnotes
- Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $12.00 to $12.05, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $11.98 to $12.08, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Grant to the reporting person of two options to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 16, 2011, the first anniversary of the date of grant.
- Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 23, 2011, the first anniversary of the date of grant.
- Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 24, 2010, the first anniversary of the date of grant.
- Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 26, 2011, the first anniversary of the date of grant.
- Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2012, the first anniversary of the date of grant.
- Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on May 12, 2012, the first anniversary of the date of grant.
Billionaire Hedge Funds
